United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62135-879_1ba47f65-782d-bcae-e063-6294a90a39a5
- Product NDC
- 62135-879
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Ondansetron
- Labeler
- Chartwell RX, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20061226
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON — 24 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62135-879-30) · 62135-879-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →